Justin Andrew Caravella

USPTO Granted Patents = 47 (Patent Applications = 22)

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 17 (Patent Applications = 17)

Average Co-Inventor Count = 8.9

ph-index = 13

Forward Citations = 337(Granted Patents)

Company Filing History:

24 out of 125

Forma Therapeutics, Inc.

Valo Early Discovery, Inc.

Camp4 Therapeutics Corporation

patents

Years Active: 2016-2025

Loading Chart...

47 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12421233 - WRN inhibitors (2025-09-23),

2. 12344609 - WRN inhibitors (2025-07-01),

3. 12319916 - Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs (2025-06-03),

4. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2025-04-14),

5. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

6. 12162888 - Carboxamides as ubiquitin-specific protease inhibitors (2024-12-10),

7. 12043623 - Purinones as ubiquitin-specific protease 1 inhibitors (2024-07-23),

8. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors (2024-06-25),

9. 11879008 - Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulator (2024-01-23),

10. 11814386 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2023-11-14),

11. 11535618 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2022-12-27),

12. 11524966 - Carboxamides as ubiquitin-specific protease inhibitors (2022-12-13),

13. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors (2022-11-15),

14. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

15. 11247987 - Inhibiting ubiquitin specific peptidase 30 (2022-02-15),

Title: Justin Andrew Caravella - Innovator from Cambridge, MA

Introduction: Justin Andrew Caravella is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Justin Andrew Caravella holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Caravella has successfully developed cutting-edge solutions that have revolutionized various industries. His inventions have not only improved efficiency but have also had a positive impact on society as a whole.

Collaborations: Throughout his career, Justin Andrew Caravella has collaborated with leading research institutions, universities, and tech companies to further advance his inventions and bring them to market. His collaborative spirit and dedication to innovation have led to successful partnerships and groundbreaking discoveries.

Conclusion: Justin Andrew Caravella's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventors. His impact on various industries is profound, and his legacy as an inventor from Cambridge, MA, continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.